100 Mg Imatinib Tablets IP

Name: 100 Mg Imatinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 600 INR
Availability: InStock

Price 600 INR/ Strip

Get a Price/Quote

MOQ : 1 Strip

100 Mg Imatinib Tablets IP Specification

Dosage Form
Tablet

Salt Composition
Imatinib Mesylate

Indication
Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST)

Enzyme Types
Non-enzymatic (Tyrosine Kinase Inhibitor)

Feature
High purity, effective for targeted cancer therapy

Ingredients
Imatinib Mesylate, excipients

Application
Treatment of certain types of cancer (CML, GIST)

Physical Color/Texture
Yellow film-coated tablets

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 Months

Prescription Status
Prescription Only

Compliance
WHO GMP, Indian Pharmacopeia standards

Packaging Type
Blister pack

Warnings
To be used under strict medical supervision

Contraindications
Hypersensitivity to Imatinib or any excipients

Tablet Shape
Round

Patient Age Group
Adults and Children (as directed by physician)

Strength
100 mg

Country of Export
India

Tablet Markings
May have breakline or logo, as per manufacturer

Drug Interactions
May interact with CYP3A4 inhibitors/inducers, anticoagulants and others

Administration Route
Oral

Adverse Reactions
Nausea, edema, muscle cramps, rash, diarrhea, fatigue

About 100 Mg Imatinib Tablets IP

Unlock advanced cancer therapy with 100 Mg Imatinib Tablets IP, reserved for enlightened treatment of Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). Each polished, yellow, round tablet delivers ace precision with 100 mg Imatinib Mesylate, meeting the latest WHO GMP and Indian Pharmacopeia standards. Supplied in a blister pack from India, these prescription-only tablets feature high purity and compliance for adults and children. Markings may include a breakline or logo as per manufacturer. Experience reliable, targeted therapy-always under strict medical supervision.

Tailored Suitability and Application

100 Mg Imatinib Tablets IP are suitable for both adults and children when prescribed by a physician. Designed for oral administration, these ace tablets are indicated specifically for the treatment of Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). Their usage type is strictly therapeutic, supporting targeted intervention in oncology settings to help patients unlock the potential for disease control.

Packaging and Availability Details

The latest stock of 100 Mg Imatinib Tablets IP is packaged securely in blister packs to ensure stability and purity. With shelf-ready stock available for immediate exchange, quotations can be provided rapidly for distributors, exporters, and traders across India. Samples may be requested, and products meet rigorous domestic market and international standards for quality assurance.

FAQ's of 100 Mg Imatinib Tablets IP:

Q: How should 100 Mg Imatinib Tablets IP be taken?

A: These tablets are administered orally as directed by a healthcare professional. It is important to follow the prescribed dosage and schedule for optimal effectiveness.

Q: What conditions are treated with Imatinib Mesylate tablets?

A: 100 Mg Imatinib Tablets IP are indicated for the treatment of Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST) in eligible patients.

Q: When is Imatinib therapy contraindicated?

A: Imatinib should not be used in patients with hypersensitivity to Imatinib or any of its excipients. Consultation with a physician is essential prior to starting therapy.

Q: Where are these Imatinib tablets produced and exported?

A: These tablets are manufactured and exported from India, complying with WHO GMP and Indian Pharmacopeia standards for quality.

Q: What interactions should be considered before usage?

A: Imatinib may interact with CYP3A4 inhibitors/inducers, anticoagulants, and other medications. Always inform your physician of all drugs you are taking before starting Imatinib.

Q: What is the main benefit of using 100 Mg Imatinib Tablets IP?

A: The tablets offer targeted cancer therapy, delivering high purity and effective disease control for selected indications under strict medical supervision.

Tell us about your requirement